Mustang Bio MBIO
NASDAQ MBIO
$0.58 +0.01 (+1.97%)
As of: Aug 21, 2026 · 2:30 PM EDT

Mustang Bio (MBIO) Revenue (2018)

Mustang Bio (MBIO) posted quarterly Revenue of $50000.0 for Q1 2018.

Mustang Bio (MBIO) Revenue (2018) Analysis & Trends

Mustang Bio (MBIO) has reported Revenue for 1 consecutive years, with $50000.0 the latest figure, recorded in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 85.91 Bn 77.91 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.87 Bn 59.68 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.18 Bn 53.04 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.96 Bn 36.87 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 31.53 Bn 28.23 Bn 992.69 Mn 1.29 Bn
7 BioNTech SE 27.79 Bn 9.40 Bn 668.28 Mn 1.06 Bn
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 425.49 Mn
9 Royalty Pharma 27.37 Bn 26.53 Bn - 674.14 Mn
10 Mustang Bio 3.90 Mn 3.90 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2018 50,000.00